Accuitive Medical Ventures is a Georgia-based venture capital firm that invests in early-stage medical device and technology companies.
Business Model:
Revenue: $14M
Employees: 2-10
Address: 2750 Premiere Pkwy
City: Duluth
State: GA
Zip: 30097
Country: US
Accuitive Medical Ventures (AMV) is a medical device venture capital firm. AMV is in business to finance and help develop early and expansion stage medical device and technology companies.
Contact Phone:
+16788121142
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2008 | AqueSys | Series B | 9M |
7/2007 | AqueSys | Series A | 1.9M |
3/2018 | MyoScience | Venture Round | 0 |
12/2006 | Softscope Medical Technologies | Series A | 4M |
2/2011 | CardioFocus | Series C | 0 |
8/2010 | Respicardia | Series C | 0 |
5/2014 | CardioFocus | Debt Financing | 0 |
5/2012 | NeoVista | Venture Round | 6M |
3/2009 | NovaLign Orthopaedics | Series B | 10M |
1/2014 | Intuity Medical | Venture Round | 5.5M |
8/2011 | Intuity Medical | Series D | 12M |
1/2018 | Intuity Medical | Venture Round | 0 |
11/2016 | Intuity Medical | Venture Round | 0 |
9/2013 | MyoScience | Series E | 0 |
3/2012 | MyoScience | Series D | 0 |
7/2008 | MyoScience | Series B | 0 |
6/2010 | AqueSys | Series C | 35M |
7/2016 | Torax Medical | Series E | 0 |
6/2015 | Sebacia | Series C | 12M |
4/2011 | Halscion, Inc. | Venture Round | 3.5M |
7/2004 | LipoSonix | Series C | 27M |
4/2009 | Torax Medical | Series C | 15M |
3/2005 | Neuronetics | Series B | 8.5M |
5/2009 | Sadra Medical | Series C | 30M |
4/2012 | WaveTec Vision | Venture Round | 0 |
9/2008 | Nevro | Series A | 21.8M |
2/2007 | Inogen | Series D | 22M |
12/2006 | Respicardia | Series A | 5.5M |
7/2011 | Nevro | Series B | 58M |
3/2009 | NeoVista | Series D | 18M |
6/2017 | Neuronetics | Series G | 0 |
6/2004 | Inogen | Series B | 6M |
2/2009 | WaveTec Vision | Series C | 20.1M |
5/2011 | WaveTec Vision | Series D | 15.9M |
7/2017 | Sebacia | Series D | 0 |
5/2007 | WaveTec Vision | Series B | 13M |
2/2011 | NeoVista | Series E | 33M |
10/2008 | Respicardia | Series B | 0 |
11/2011 | AcuFocus | Private Equity Round | 0 |
9/2006 | NeoVista | Series B | 26M |
12/2008 | CELLutions Biosystems | Series B | 8.8M |
9/2014 | AcuFocus | Venture Round | 0 |
3/2013 | Nevro | Series C | 0 |
1/2007 | AcuFocus | Series D | 0 |
12/2006 | NeoVista | Series C | 41M |
10/2009 | Halscion, Inc. | Venture Round | 6M |
9/2012 | Torax Medical | Series D | 0 |
6/2012 | Halscion, Inc. | Debt Financing | 4.3M |
1/2014 | AqueSys | Series D | 43.6M |
6/2007 | CELLutions Biosystems | Series B | 7M |
12/2007 | AxoGen | Post-IPO Equity | 12.1M |
8/2012 | Intuity Medical | Venture Round | 12M |
3/2018 | MyoScience | Venture Round | 0 |
1/2018 | Intuity Medical | Venture Round | 0 |
7/2017 | Sebacia | Series D | 0 |
6/2017 | Neuronetics | Series G | 0 |
11/2016 | Intuity Medical | Venture Round | 0 |
7/2016 | Torax Medical | Series E | 0 |
6/2015 | Sebacia | Series C | 0 |
9/2014 | AcuFocus | Venture Round | 0 |
5/2014 | CardioFocus | Debt Financing | 0 |
1/2014 | Intuity Medical | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|